Bacteriophage renaissance: Could ‘hungry’ viruses save us from antibiotic resistance?
ausdoc,
Phage therapy has a tumultuous history, but Professor Jon Iredell thinks it will go mainstream within five years.
Phage therapy has a tumultuous history, but Professor Jon Iredell thinks it will go mainstream within five years.
By Andy Tay, PhD Overuse of antibiotics has accelerated the emergence of antimicrobial-resistant (AMR) bacterial species.
A trial to assess bacteriophage, or “phage,” therapy, which utilizes a virus to target specific bacteria and leave behind other…
After 700 days of antibiotic treatment, the infection of a 30-year-old bombing attack victim still raged.